These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7703589)

  • 1. Use of a direct thrombin inhibitor (argatroban) during pulse-spray thrombolysis in experimental thrombosis.
    Valji K; Arun K; Bookstein JJ
    J Vasc Interv Radiol; 1995; 6(1):91-5. PubMed ID: 7703589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of adjunctive intrathrombic heparin with pulse spray thrombolysis in rabbit inferior vena cava thrombosis.
    Valji K; Bookstein JJ
    Invest Radiol; 1992 Nov; 27(11):912-7. PubMed ID: 1464509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intrathrombic administration of prostaglandin E1 during pulse-spray thrombolysis with tissue-type plasminogen activator in experimental thrombosis.
    Valji K; Bookstein JJ
    Radiology; 1993 Mar; 186(3):873-6. PubMed ID: 8430201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator.
    Jang IK; Gold HK; Leinbach RC; Fallon JT; Collen D
    Circ Res; 1990 Dec; 67(6):1552-61. PubMed ID: 2123135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented pulse-spray thrombolysis with tPA by early pulsed intrathrombic plasminogen enrichment.
    Lim GM; Bookstein JJ
    J Vasc Interv Radiol; 1998; 9(4):618-25. PubMed ID: 9684833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of thrombolysis and prevention of thrombus formation by local drug delivery with a double-occlusion balloon catheter.
    Tomaru T; Fujimori Y; Nakamura F; Aoki N; Sakamoto Y; Kawai K; Omata M; Uchida Y
    Heart Vessels; 1996; 11(3):123-32. PubMed ID: 8897061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase.
    Sabatine MS; Tu TM; Jang IK
    J Thromb Thrombolysis; 2000 Oct; 10(2):189-96. PubMed ID: 11005941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin and the thrombin inhibitor argatroban enhance fibrinolysis by infused or bolus-injected saruplase (r-scu-PA) in rabbit femoral artery thrombosis.
    Schneider J
    Thromb Res; 1991 Dec; 64(6):677-89. PubMed ID: 1798957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of argatroban and heparin on thrombus formation and tissue plasminogen activator-induced thrombolysis in a microvascular thrombosis model.
    Yamada K; Tsuji H; Kimura S; Kato H; Yano S; Ukimura N; Yamada Y; Nakagawa K; Nakagawa M
    Thromb Res; 2003 Jan; 109(1):55-64. PubMed ID: 12679132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
    Jang IK; Brown DF; Giugliano RP; Anderson HV; Losordo D; Nicolau JC; Dutra OP; Bazzino O; Viamonte VM; Norbady R; Liprandi AS; Massey TJ; Dinsmore R; Schwarz RP
    J Am Coll Cardiol; 1999 Jun; 33(7):1879-85. PubMed ID: 10362188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse-spray pharmacomechanical thrombolysis of thrombosed hemodialysis access grafts: long-term experience and comparison of original and current techniques.
    Valji K; Bookstein JJ; Roberts AC; Oglevie SB; Pittman C; O'Neill MP
    AJR Am J Roentgenol; 1995 Jun; 164(6):1495-500; discussion 1501-3. PubMed ID: 7754901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter-directed thrombolysis with argatroban and tPA for massive iliac and femoropopliteal vein thrombosis.
    Sharifi M; Bay C; Nowroozi S; Bentz S; Valeros G; Memari S
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1586-1590. PubMed ID: 23377239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of argatroban and catheter-directed thrombolysis with alteplase in an oncology patient with heparin-induced thrombocytopenia with thrombosis.
    Dee B; Lombardi Thomas L; Gulbis A
    Am J Health Syst Pharm; 2014 May; 71(9):711-6. PubMed ID: 24733133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis with intrathrombic injection of urokinase and tissue-type plasminogen activator. Results in a new model of subacute venous thrombosis.
    Valji K; Bookstein JJ
    Invest Radiol; 1987 Jan; 22(1):23-7. PubMed ID: 3102398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented experimental pulse-spray thrombolysis with tissue plasminogen activator, enabling dose reduction by one or more orders of magnitude.
    Bookstein JJ; Bookstein FL
    J Vasc Interv Radiol; 2000 Mar; 11(3):299-303. PubMed ID: 10735423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of reocclusion by MCI-9038, a thrombin inhibitor, following t-PA-induced thrombolysis in a canine model of femoral arterial thrombosis.
    Mellott MJ; Connolly TM; York SJ; Bush LR
    Thromb Haemost; 1990 Dec; 64(4):526-34. PubMed ID: 2128137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of thrombolytic efficacy of tissue-type plasminogen activator by adjuvants in the guinea pig thrombosis model.
    Nishiyama H; Umemura K; Saniabadi AR; Takiguchi Y; Uematsu T; Nakashima M
    Eur J Pharmacol; 1994 Oct; 264(2):191-8. PubMed ID: 7851482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary thrombosis/thrombolysis in pigs: effects of heparin, ASA, and the thrombin inhibitor inogatran.
    Uriuda Y; Wang QD; Hatori N; Nordlander R; Sjöquist PO; Mattsson C; Rydén L
    J Pharmacol Toxicol Methods; 1998 Mar; 39(2):81-9. PubMed ID: 9694166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
    Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
    Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.